Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice

被引:178
作者
Kim, SJ [1 ]
Uehara, H [1 ]
Karashima, T [1 ]
Mccarty, M [1 ]
Shih, N [1 ]
Fidler, IJ [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
来源
NEOPLASIA | 2001年 / 3卷 / 01期
关键词
prostate cancer; IL-8; angiogenesis; metastasis;
D O I
10.1038/sj.neo.7900124
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We determined whether the expression of interleukin-8 (IL-8) by human prostate cancer cells correlates with induction of angiogenesis, tumorigenicity, and production of metastasis. Low and high IL-8-producing clones were isolated from the heterogeneous PC-3 human prostate cancer cell line, The secretion of IL-8 protein correlated with transcriptional activity and levels of IL-8 mRNA. Ail PC-3 cells expressed both IL-8 receptors, CXCR1 and CXCR2, The low and high IL-8-producing clones were injected into the prostate of nude mice. Titration studies indicated that PC-3 cells expressing high levels of IL-8 were highly tumorigenic, producing rapidly growing, highly vascularized prostate tumors with and a 100% incidence of lymph node metastasis. Low IL-8-expressing PC-3 cells were less tumorigenic, producing slower growing and less vascularized primary tumors and a significantly lower incidence of metastasis. In situ hybridization (ISH) analysis of the tumors for expression of genes that regulate angiogenesis and metastasis showed that the expression level of IL-8, matrix metalloproteinases, vascular endothelial growth factor (VEGF), and E-cadherin corresponded with microvascular density and biological behavior of the prostate cancers in nude mice, Collectively, the data show that the expression level of IL-8 in human prostate cancer cells is associated with angiogenesis, tumorigenicity, and metastasis.
引用
收藏
页码:33 / 42
页数:10
相关论文
共 55 条
[1]  
*AM CANC SOC, 2000, CANC FACTS FIG, P1
[2]   Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice [J].
Arenberg, DA ;
Kunkel, SL ;
Polverini, PJ ;
Glass, M ;
Burdick, MD ;
Strieter, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) :2792-2802
[3]   ANGIOGENESIS INHIBITION - A REVIEW [J].
AUERBACH, W ;
AUERBACH, R .
PHARMACOLOGY & THERAPEUTICS, 1994, 63 (03) :265-311
[4]   REVERSAL OF MULTIDRUG-RESISTANCE IN MURINE FIBROSARCOMA CELLS BY THIOXANTHENE FLUPENTIXOL [J].
FAN, D ;
POSTE, G ;
SEID, C ;
EARNEST, LE ;
BULL, T ;
CLYNE, RK ;
FIDLER, IJ .
INVESTIGATIONAL NEW DRUGS, 1994, 12 (03) :185-195
[5]   Angiogenesis and prostate cancer: In vivo and in vitro expression of angiogenesis factors by prostate cancer cells [J].
Ferrer, FA ;
Miller, LJ ;
Andrawis, RI ;
Kurtzman, SH ;
Albertsen, PC ;
Laudone, VP ;
Kreutzer, DL .
UROLOGY, 1998, 51 (01) :161-167
[6]  
Fidler I.J., 1997, MOL PATHOLOGY GASTRO, P147
[7]   ORTHOTOPIC IMPLANTATION OF HUMAN COLON CARCINOMAS INTO NUDE-MICE PROVIDES A VALUABLE MODEL FOR THE BIOLOGY AND THERAPY OF METASTASIS [J].
FIDLER, IJ .
CANCER AND METASTASIS REVIEWS, 1991, 10 (03) :229-243
[8]   Critical determinants of cancer metastasis: rationale for therapy [J].
Fidler, IJ .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (Suppl 1) :S3-S10
[9]  
FIDLER IJ, 1990, CANCER RES, V50, P6130
[10]   THE IMPLICATIONS OF ANGIOGENESIS FOR THE BIOLOGY AND THERAPY OF CANCER METASTASIS [J].
FIDLER, IJ ;
ELLIS, LM .
CELL, 1994, 79 (02) :185-188